Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers

Cobalamin or vitamin B12 (B12) is a cofactor for methionine synthase and methylmalonyl-CoA mutase, two enzymes implicated in key pathways for cell proliferation: methylation, purine synthesis, succinylation and ATP production. Ensuring these functions in cancer cells therefore requires important cob...

Full description

Bibliographic Details
Main Authors: Valentin Lacombe, Guy Lenaers, Geoffrey Urbanski
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/10/2058
_version_ 1797497239977852928
author Valentin Lacombe
Guy Lenaers
Geoffrey Urbanski
author_facet Valentin Lacombe
Guy Lenaers
Geoffrey Urbanski
author_sort Valentin Lacombe
collection DOAJ
description Cobalamin or vitamin B12 (B12) is a cofactor for methionine synthase and methylmalonyl-CoA mutase, two enzymes implicated in key pathways for cell proliferation: methylation, purine synthesis, succinylation and ATP production. Ensuring these functions in cancer cells therefore requires important cobalamin needs and its uptake through the transcobalamin II receptor (TCII-R). Thus, both the TCII-R and the cobalamin-dependent metabolic pathways constitute promising therapeutic targets to inhibit cancer development. However, the link between cobalamin and solid cancers is not limited to cellular metabolism, as it also involves the circulating transcobalamins I and II (TCI or haptocorrin and TCII) carrier proteins, encoded by <i>TCN1</i> and <i>TCN2</i>, respectively. In this respect, elevations of B12, TCI and TCII concentrations in plasma are associated with cancer onset and relapse, and with the presence of metastases and worse prognosis. In addition, <i>TCN1</i> and <i>TCN2</i> overexpressions are associated with chemoresistance and a proliferative phenotype, respectively. Here we review the involvement of cobalamin and transcobalamins in cancer diagnosis and prognosis, and as potential therapeutic targets. We further detail the relationship between cobalamin-dependent metabolic pathways in cancer cells and the transcobalamins’ abundancies in plasma and tumors, to ultimately hypothesize screening and therapeutic strategies linking these aspects.
first_indexed 2024-03-10T03:14:40Z
format Article
id doaj.art-afe7ad6db89042a28f26f6766c3b0ca3
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T03:14:40Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-afe7ad6db89042a28f26f6766c3b0ca32023-11-23T12:29:22ZengMDPI AGNutrients2072-66432022-05-011410205810.3390/nu14102058Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid CancersValentin Lacombe0Guy Lenaers1Geoffrey Urbanski2MitoLab Team, MitoVasc Institut, CNRS UMR6015, INSERM U1083, Angers University, 49000 Angers, FranceMitoLab Team, MitoVasc Institut, CNRS UMR6015, INSERM U1083, Angers University, 49000 Angers, FranceMitoLab Team, MitoVasc Institut, CNRS UMR6015, INSERM U1083, Angers University, 49000 Angers, FranceCobalamin or vitamin B12 (B12) is a cofactor for methionine synthase and methylmalonyl-CoA mutase, two enzymes implicated in key pathways for cell proliferation: methylation, purine synthesis, succinylation and ATP production. Ensuring these functions in cancer cells therefore requires important cobalamin needs and its uptake through the transcobalamin II receptor (TCII-R). Thus, both the TCII-R and the cobalamin-dependent metabolic pathways constitute promising therapeutic targets to inhibit cancer development. However, the link between cobalamin and solid cancers is not limited to cellular metabolism, as it also involves the circulating transcobalamins I and II (TCI or haptocorrin and TCII) carrier proteins, encoded by <i>TCN1</i> and <i>TCN2</i>, respectively. In this respect, elevations of B12, TCI and TCII concentrations in plasma are associated with cancer onset and relapse, and with the presence of metastases and worse prognosis. In addition, <i>TCN1</i> and <i>TCN2</i> overexpressions are associated with chemoresistance and a proliferative phenotype, respectively. Here we review the involvement of cobalamin and transcobalamins in cancer diagnosis and prognosis, and as potential therapeutic targets. We further detail the relationship between cobalamin-dependent metabolic pathways in cancer cells and the transcobalamins’ abundancies in plasma and tumors, to ultimately hypothesize screening and therapeutic strategies linking these aspects.https://www.mdpi.com/2072-6643/14/10/2058neoplasmsvitamin B12transcobalaminsmethioninemetabolismmethylation
spellingShingle Valentin Lacombe
Guy Lenaers
Geoffrey Urbanski
Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers
Nutrients
neoplasms
vitamin B12
transcobalamins
methionine
metabolism
methylation
title Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers
title_full Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers
title_fullStr Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers
title_full_unstemmed Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers
title_short Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins’ Synthesis in Solid Cancers
title_sort diagnostic and therapeutic perspectives associated to cobalamin dependent metabolism and transcobalamins synthesis in solid cancers
topic neoplasms
vitamin B12
transcobalamins
methionine
metabolism
methylation
url https://www.mdpi.com/2072-6643/14/10/2058
work_keys_str_mv AT valentinlacombe diagnosticandtherapeuticperspectivesassociatedtocobalamindependentmetabolismandtranscobalaminssynthesisinsolidcancers
AT guylenaers diagnosticandtherapeuticperspectivesassociatedtocobalamindependentmetabolismandtranscobalaminssynthesisinsolidcancers
AT geoffreyurbanski diagnosticandtherapeuticperspectivesassociatedtocobalamindependentmetabolismandtranscobalaminssynthesisinsolidcancers